Regeneron Pharmaceuticals (REGN) Cash from Operations (QoQ) (2009 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7.84% |
| Dec 31, 2025 | -27.68% |
| Sep 30, 2025 | 41.45% |
| Jun 30, 2025 | 9.50% |
| Mar 31, 2025 | -17.24% |
| Dec 31, 2024 | -2.20% |
| Sep 30, 2024 | 264.75% |
| Jun 30, 2024 | -76.60% |
| Mar 31, 2024 | 38.80% |
| Dec 31, 2023 | -2.21% |
| Sep 30, 2023 | 8.99% |
| Jun 30, 2023 | -25.24% |
| Mar 31, 2023 | -20.48% |
| Dec 31, 2022 | 173.48% |
| Sep 30, 2022 | 11.43% |
| Jun 30, 2022 | -73.15% |
| Mar 31, 2022 | -11.41% |
| Dec 31, 2021 | -30.50% |
| Sep 30, 2021 | 444.69% |
| Jun 30, 2021 | -6.25% |
| Mar 31, 2021 | -45.69% |
| Dec 31, 2020 | 584.07% |
| Sep 30, 2020 | -126.96% |
| Jun 30, 2020 | 35.16% |
| Mar 31, 2020 | -11.35% |
| Dec 31, 2019 | 41.29% |
| Sep 30, 2019 | 195.96% |
| Jun 30, 2019 | -79.01% |
| Mar 31, 2019 | 23.08% |
| Dec 31, 2018 | 60.92% |
| Sep 30, 2018 | 14.77% |
| Jun 30, 2018 | -36.23% |
| Mar 31, 2018 | 9.15% |
| Dec 31, 2017 | 36.67% |
| Sep 30, 2017 | 1,456.99% |
| Jun 30, 2017 | -108.59% |
| Mar 31, 2017 | -8.83% |
| Dec 31, 2016 | -40.04% |
| Sep 30, 2016 | 62.96% |
| Jun 30, 2016 | 787.99% |
| Mar 31, 2016 | -84.04% |
| Dec 31, 2015 | -68.44% |
| Sep 30, 2015 | 246.29% |
| Jun 30, 2015 | 353.45% |
| Mar 31, 2015 | -151.33% |
| Dec 31, 2014 | 20.60% |
| Sep 30, 2014 | -51.15% |
| Jun 30, 2014 | 528.49% |
| Mar 31, 2014 | -81.00% |
| Dec 31, 2013 | 204.72% |
| Sep 30, 2013 | -27.86% |
| Jun 30, 2013 | 48.60% |
| Mar 31, 2013 | -7.44% |
| Dec 31, 2012 | 4,012.05% |
| Sep 30, 2012 | 96.96% |
| Jun 30, 2012 | 9.95% |
| Mar 31, 2012 | -72.99% |
| Dec 31, 2011 | -7.66% |
| Sep 30, 2011 | -37.25% |
| Jun 30, 2011 | -221.83% |
| Mar 31, 2011 | 74.10% |
| Dec 31, 2010 | -125.29% |
| Sep 30, 2010 | 1,462.88% |
| Jun 30, 2010 | -23.72% |
| Mar 31, 2010 | 79.36% |
| Dec 31, 2009 | -372.45% |